APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oncology Treatment Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oncology Treatment Drug Industry Growth and Trends Forecast to 2032

Report ID 17401897012 January 2026123 pages

Choose your research edition.

Industry ResearchOncology Treatment Drug Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology Treatment Drug Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Oncology Treatment Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology Treatment Drug Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology Treatment Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

According to APO Research, the global Oncology Treatment Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oncology Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oncology Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology Treatment Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Oncology Treatment Drug market include Takeda, Eisai, Teva, Sanofi, Johnson & Johnson, Novartis, Merck KGaA, Roche and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oncology Treatment Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oncology Treatment Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncology Treatment Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncology Treatment Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Oncology Treatment Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oncology Treatment Drug Market by Company

Takeda

Eisai

Teva

Sanofi

Johnson & Johnson

Novartis

Merck KGaA

Roche

Eli Lilly

Pfizer

Bayer

Amgen

AbbVie

AstraZeneca

Otsuka

Merck & Co.

Ipsen

Gilead Sciences

Celgene

Bristol-Myers Squibb

Biogen Idec

Astellas

Oncology Treatment Drug Segment by Type

Immunotherapy (Biologic Therapy)

Chemotherapy

Hormonal Therapy

Targeted Therapy

Others

Oncology Treatment Drug Segment by Application

Respiratory/Lung Cancer

Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Blood Cancer

Others

Oncology Treatment Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Treatment Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Oncology Treatment Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Oncology Treatment Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Oncology Treatment Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Oncology Treatment Drug Market Share by Region (2021-2026) Table 4. Global Oncology Treatment Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Oncology Treatment Drug Market Share by Region (2027-2032) Table 6. Global Oncology Treatment Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Oncology Treatment Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Oncology Treatment Drug Market Size Share by Type (2021-2026) Table 9. Global Oncology Treatment Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Oncology Treatment Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Oncology Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Oncology Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Oncology Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Oncology Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Oncology Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Oncology Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Oncology Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Oncology Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Oncology Treatment Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Oncology Treatment Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Oncology Treatment Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Oncology Treatment Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Oncology Treatment Drug Market Size Share by Application (2021-2026) Table 24. Global Oncology Treatment Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Oncology Treatment Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Oncology Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Oncology Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Oncology Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Oncology Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Oncology Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Oncology Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Oncology Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Oncology Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Oncology Treatment Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Oncology Treatment Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Oncology Treatment Drug Industry Trends Table 37. Oncology Treatment Drug Industry Drivers Table 38. Oncology Treatment Drug Industry Opportunities and Challenges Table 39. Oncology Treatment Drug Industry Restraints Table 40. Global Oncology Treatment Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Oncology Treatment Drug Revenue Market Share by Company (2021-2026) Table 42. Global Oncology Treatment Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Oncology Treatment Drug Key Company Headquarters & Area Served Table 44. Global Oncology Treatment Drug Company, Product Type & Application Table 45. Global Oncology Treatment Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Oncology Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Oncology Treatment Drug Product Portfolio Table 52. Takeda Recent Development Table 53. Eisai Company Information Table 54. Eisai Business Overview Table 55. Eisai Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eisai Oncology Treatment Drug Product Portfolio Table 57. Eisai Recent Development Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Teva Oncology Treatment Drug Product Portfolio Table 62. Teva Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sanofi Oncology Treatment Drug Product Portfolio Table 67. Sanofi Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Oncology Treatment Drug Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Oncology Treatment Drug Product Portfolio Table 77. Novartis Recent Development Table 78. Merck KGaA Company Information Table 79. Merck KGaA Business Overview Table 80. Merck KGaA Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Merck KGaA Oncology Treatment Drug Product Portfolio Table 82. Merck KGaA Recent Development Table 83. Roche Company Information Table 84. Roche Business Overview Table 85. Roche Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Roche Oncology Treatment Drug Product Portfolio Table 87. Roche Recent Development Table 88. Eli Lilly Company Information Table 89. Eli Lilly Business Overview Table 90. Eli Lilly Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Eli Lilly Oncology Treatment Drug Product Portfolio Table 92. Eli Lilly Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Pfizer Oncology Treatment Drug Product Portfolio Table 97. Pfizer Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bayer Oncology Treatment Drug Product Portfolio Table 102. Bayer Recent Development Table 103. Amgen Company Information Table 104. Amgen Business Overview Table 105. Amgen Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Amgen Oncology Treatment Drug Product Portfolio Table 107. Amgen Recent Development Table 108. AbbVie Company Information Table 109. AbbVie Business Overview Table 110. AbbVie Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. AbbVie Oncology Treatment Drug Product Portfolio Table 112. AbbVie Recent Development Table 113. AstraZeneca Company Information Table 114. AstraZeneca Business Overview Table 115. AstraZeneca Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AstraZeneca Oncology Treatment Drug Product Portfolio Table 117. AstraZeneca Recent Development Table 118. Otsuka Company Information Table 119. Otsuka Business Overview Table 120. Otsuka Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Otsuka Oncology Treatment Drug Product Portfolio Table 122. Otsuka Recent Development Table 123. Merck & Co. Company Information Table 124. Merck & Co. Business Overview Table 125. Merck & Co. Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Merck & Co. Oncology Treatment Drug Product Portfolio Table 127. Merck & Co. Recent Development Table 128. Ipsen Company Information Table 129. Ipsen Business Overview Table 130. Ipsen Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Ipsen Oncology Treatment Drug Product Portfolio Table 132. Ipsen Recent Development Table 133. Gilead Sciences Company Information Table 134. Gilead Sciences Business Overview Table 135. Gilead Sciences Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Gilead Sciences Oncology Treatment Drug Product Portfolio Table 137. Gilead Sciences Recent Development Table 138. Celgene Company Information Table 139. Celgene Business Overview Table 140. Celgene Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Celgene Oncology Treatment Drug Product Portfolio Table 142. Celgene Recent Development Table 143. Bristol-Myers Squibb Company Information Table 144. Bristol-Myers Squibb Business Overview Table 145. Bristol-Myers Squibb Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Bristol-Myers Squibb Oncology Treatment Drug Product Portfolio Table 147. Bristol-Myers Squibb Recent Development Table 148. Biogen Idec Company Information Table 149. Biogen Idec Business Overview Table 150. Biogen Idec Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Biogen Idec Oncology Treatment Drug Product Portfolio Table 152. Biogen Idec Recent Development Table 153. Astellas Company Information Table 154. Astellas Business Overview Table 155. Astellas Oncology Treatment Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Astellas Oncology Treatment Drug Product Portfolio Table 157. Astellas Recent Development Table 158. North America Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Oncology Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Oncology Treatment Drug Market Share by Country (2021-2026) Table 161. North America Oncology Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Oncology Treatment Drug Market Share Forecast by Country (2027-2032) Table 163. Europe Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Oncology Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Oncology Treatment Drug Market Share by Country (2021-2026) Table 166. Europe Oncology Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Oncology Treatment Drug Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Oncology Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Oncology Treatment Drug Market Share by Country (2021-2026) Table 171. Asia-Pacific Oncology Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Oncology Treatment Drug Market Share Forecast by Country (2027-2032) Table 173. Latin America Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Oncology Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Oncology Treatment Drug Market Share by Country (2021-2026) Table 176. Latin America Oncology Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Oncology Treatment Drug Market Share Forecast by Country (2027-2032) Table 178. Middle East & Africa Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East & Africa Oncology Treatment Drug Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East & Africa Oncology Treatment Drug Market Share by Country (2021-2026) Table 181. Middle East & Africa Oncology Treatment Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East & Africa Oncology Treatment Drug Market Share Forecast by Country (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Oncology Treatment Drug Product Image Figure 3. Global Oncology Treatment Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Oncology Treatment Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Oncology Treatment Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Oncology Treatment Drug Market Share by Region (2021-2032) Figure 7. North America Oncology Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Oncology Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Oncology Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Oncology Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Oncology Treatment Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Immunotherapy (Biologic Therapy) Image Figure 13. Global Immunotherapy (Biologic Therapy) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Chemotherapy Image Figure 15. Global Chemotherapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Hormonal Therapy Image Figure 17. Global Hormonal Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Targeted Therapy Image Figure 19. Global Targeted Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Oncology Treatment Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Oncology Treatment Drug Market Share by Type 2025 VS 2032 Figure 24. North America Oncology Treatment Drug Market Size Share by Type (2021-2032) Figure 25. Europe Oncology Treatment Drug Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Oncology Treatment Drug Market Size Share by Type (2021-2032) Figure 27. Latin America Oncology Treatment Drug Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Oncology Treatment Drug Market Size Share by Type (2021-2032) Figure 29. Respiratory/Lung Cancer Image Figure 30. Global Respiratory/Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Prostate Cancer Image Figure 32. Global Prostate Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Breast Cancer Image Figure 34. Global Breast Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Gastrointestinal Cancer Image Figure 36. Global Gastrointestinal Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Blood Cancer Image Figure 38. Global Blood Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Others Image Figure 40. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global Oncology Treatment Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Oncology Treatment Drug Market Share by Application 2025 VS 2032 Figure 43. North America Oncology Treatment Drug Market Size Share by Application (2021-2032) Figure 44. Europe Oncology Treatment Drug Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific Oncology Treatment Drug Market Size Share by Application (2021-2032) Figure 46. Latin America Oncology Treatment Drug Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa Oncology Treatment Drug Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 Oncology Treatment Drug Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America Oncology Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America Oncology Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America Oncology Treatment Drug Market Share by Country (2021-2032) Figure 53. Europe Oncology Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Oncology Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Oncology Treatment Drug Market Share by Country (2021-2032) Figure 56. Asia-Pacific Oncology Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific Oncology Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific Oncology Treatment Drug Market Share by Country (2021-2032) Figure 59. Latin America Oncology Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Oncology Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Oncology Treatment Drug Market Share by Country (2021-2032) Figure 62. Middle East & Africa Oncology Treatment Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa Oncology Treatment Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa Oncology Treatment Drug Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Immunotherapy (Biologic Therapy)
  • Chemotherapy
  • Hormonal Therapy
  • Targeted Therapy
  • Others
Applications
  • Respiratory/Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Blood Cancer
  • Others
Companies covered
  • Takeda
  • Eisai
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck KGaA
  • Roche
  • Eli Lilly
  • Pfizer
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Otsuka
  • Merck & Co.
  • Ipsen
  • Gilead Sciences
  • Celgene
  • Bristol-Myers Squibb
  • Biogen Idec
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Oncology Treatment Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Oncology Treatment Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Oncology Treatment Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Oncology Treatment Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Oncology Treatment Drug Market Size (2021-2032)
  8. 1.5.1 North America Oncology Treatment Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Oncology Treatment Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Oncology Treatment Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Oncology Treatment Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Oncology Treatment Drug Market Size Growth Rate (2021-2032)
2 Oncology Treatment Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Immunotherapy (Biologic Therapy)
  3. 2.1.2 Chemotherapy
  4. 2.1.3 Hormonal Therapy
  5. 2.1.4 Targeted Therapy
  6. 2.1.5 Others
  7. 2.2 Global Oncology Treatment Drug Market Size by Type
  8. 2.2.1 Global Oncology Treatment Drug Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Oncology Treatment Drug Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Oncology Treatment Drug Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Oncology Treatment Drug Market Size by Regions
  12. 2.3.1 North America Oncology Treatment Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Oncology Treatment Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Oncology Treatment Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Oncology Treatment Drug Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Oncology Treatment Drug Market Size Breakdown by Type (2021-2026)
3 Oncology Treatment Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Respiratory/Lung Cancer
  3. 3.1.2 Prostate Cancer
  4. 3.1.3 Breast Cancer
  5. 3.1.4 Gastrointestinal Cancer
  6. 3.1.5 Blood Cancer
  7. 3.1.6 Others
  8. 3.2 Global Oncology Treatment Drug Market Size by Application
  9. 3.2.1 Global Oncology Treatment Drug Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Oncology Treatment Drug Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Oncology Treatment Drug Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Oncology Treatment Drug Market Size by Regions
  13. 3.3.1 North America Oncology Treatment Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Oncology Treatment Drug Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Oncology Treatment Drug Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Oncology Treatment Drug Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Oncology Treatment Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Oncology Treatment Drug Industry Trends
  2. 4.2 Oncology Treatment Drug Industry Drivers
  3. 4.3 Oncology Treatment Drug Industry Opportunities and Challenges
  4. 4.4 Oncology Treatment Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Oncology Treatment Drug Revenue (2021-2026)
  2. 5.2 Global Oncology Treatment Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Oncology Treatment Drug Key Company Headquarters & Area Served
  4. 5.4 Global Oncology Treatment Drug Company, Product Type & Application
  5. 5.5 Global Oncology Treatment Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Oncology Treatment Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Oncology Treatment Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Oncology Treatment Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Oncology Treatment Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Oncology Treatment Drug Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Teva Oncology Treatment Drug Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Oncology Treatment Drug Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Oncology Treatment Drug Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Oncology Treatment Drug Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Merck KGaA
  38. 6.7.1 Merck KGaA Company Information
  39. 6.7.2 Merck KGaA Business Overview
  40. 6.7.3 Merck KGaA Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Merck KGaA Oncology Treatment Drug Product Portfolio
  42. 6.7.5 Merck KGaA Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Roche Oncology Treatment Drug Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Eli Lilly
  50. 6.9.1 Eli Lilly Company Information
  51. 6.9.2 Eli Lilly Business Overview
  52. 6.9.3 Eli Lilly Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Eli Lilly Oncology Treatment Drug Product Portfolio
  54. 6.9.5 Eli Lilly Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Oncology Treatment Drug Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Bayer
  62. 6.11.1 Bayer Company Information
  63. 6.11.2 Bayer Business Overview
  64. 6.11.3 Bayer Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bayer Oncology Treatment Drug Product Portfolio
  66. 6.11.5 Bayer Recent Developments
  67. 6.12 Amgen
  68. 6.12.1 Amgen Company Information
  69. 6.12.2 Amgen Business Overview
  70. 6.12.3 Amgen Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Amgen Oncology Treatment Drug Product Portfolio
  72. 6.12.5 Amgen Recent Developments
  73. 6.13 AbbVie
  74. 6.13.1 AbbVie Company Information
  75. 6.13.2 AbbVie Business Overview
  76. 6.13.3 AbbVie Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 AbbVie Oncology Treatment Drug Product Portfolio
  78. 6.13.5 AbbVie Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AstraZeneca Oncology Treatment Drug Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
  85. 6.15 Otsuka
  86. 6.15.1 Otsuka Company Information
  87. 6.15.2 Otsuka Business Overview
  88. 6.15.3 Otsuka Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Otsuka Oncology Treatment Drug Product Portfolio
  90. 6.15.5 Otsuka Recent Developments
  91. 6.16 Merck & Co.
  92. 6.16.1 Merck & Co. Company Information
  93. 6.16.2 Merck & Co. Business Overview
  94. 6.16.3 Merck & Co. Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Merck & Co. Oncology Treatment Drug Product Portfolio
  96. 6.16.5 Merck & Co. Recent Developments
  97. 6.17 Ipsen
  98. 6.17.1 Ipsen Company Information
  99. 6.17.2 Ipsen Business Overview
  100. 6.17.3 Ipsen Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Ipsen Oncology Treatment Drug Product Portfolio
  102. 6.17.5 Ipsen Recent Developments
  103. 6.18 Gilead Sciences
  104. 6.18.1 Gilead Sciences Company Information
  105. 6.18.2 Gilead Sciences Business Overview
  106. 6.18.3 Gilead Sciences Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Gilead Sciences Oncology Treatment Drug Product Portfolio
  108. 6.18.5 Gilead Sciences Recent Developments
  109. 6.19 Celgene
  110. 6.19.1 Celgene Company Information
  111. 6.19.2 Celgene Business Overview
  112. 6.19.3 Celgene Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Celgene Oncology Treatment Drug Product Portfolio
  114. 6.19.5 Celgene Recent Developments
  115. 6.20 Bristol-Myers Squibb
  116. 6.20.1 Bristol-Myers Squibb Company Information
  117. 6.20.2 Bristol-Myers Squibb Business Overview
  118. 6.20.3 Bristol-Myers Squibb Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Bristol-Myers Squibb Oncology Treatment Drug Product Portfolio
  120. 6.20.5 Bristol-Myers Squibb Recent Developments
  121. 6.21 Biogen Idec
  122. 6.21.1 Biogen Idec Company Information
  123. 6.21.2 Biogen Idec Business Overview
  124. 6.21.3 Biogen Idec Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Biogen Idec Oncology Treatment Drug Product Portfolio
  126. 6.21.5 Biogen Idec Recent Developments
  127. 6.22 Astellas
  128. 6.22.1 Astellas Company Information
  129. 6.22.2 Astellas Business Overview
  130. 6.22.3 Astellas Oncology Treatment Drug Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Astellas Oncology Treatment Drug Product Portfolio
  132. 6.22.5 Astellas Recent Developments
7 North America
  1. 7.1 North America Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Oncology Treatment Drug Market Size by Country (2021-2026)
  3. 7.3 North America Oncology Treatment Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Oncology Treatment Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Oncology Treatment Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Oncology Treatment Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Oncology Treatment Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Oncology Treatment Drug Market Size by Country (2021-2026)
  3. 10.3 South America Oncology Treatment Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Oncology Treatment Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Oncology Treatment Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Oncology Treatment Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst